Trails Edge Capital Partners, LP / ACAD
Trails Edge Capital Partners, LP’s Acadia Pharmaceuticals Inc Position
Does Trails Edge Capital Partners, LP own Acadia Pharmaceuticals Inc (ACAD)? Not currently — the last reported position was 1.42M shares worth $38M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$38M
Q4 2025
Shares
1.42M
% of Portfolio
+9.37%
Quarters Held
1
position exited
Position History ACAD
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2025 | 1.42M | $38M | +9.37% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Trails Edge Capital Partners, LP’s full portfolio or all institutional holders of ACAD.